Wells Fargo & Company Publication of Suppl.Prospcts (2013A)

TIDMAF31

RNS Number : 2013A

Wells Fargo & Company

18 January 2024

Publication of Supplementary Prospectus

The following prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Supplementary prospectus dated 18 January 2024 (the "Supplementary Prospectus") further supplementing the base prospectus dated 6 April 2023 relating to the Wells Fargo & Company U.S.$50,000,000,000 euro medium term note programme, as supplemented by the supplementary prospectuses dated 25 May 2023, 29 August 2023 and 14 November 2023 (the "Base Prospectus").

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/2013A_1-2024-1-18.pdf

A copy of the Supplementary Prospectus will be submitted to the National Storage Mechanism and will shortly be available for inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information, please contact

Sandra Galvis

Senior Lead Counsel & Executive Director

Wells Fargo & Company

[e-mail]

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Supplementary Prospectus or Base Prospectus (collectively, the "Prospectus") may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PSPQVLFFZFLBBBE

(END) Dow Jones Newswires

January 18, 2024 11:06 ET (16:06 GMT)